RTR HealthTech audits how your lab spends, procures, disposes and reports — then turns the gaps into a costed action plan that protects gross margin and strengthens operational control. Scope 3 and carbon outcomes are built in, not bolted on.
Methodology aligned with
Built for SME labs in diagnostics, biotech, contract testing, research and life sciences.
We help laboratories, healthcare providers and research organisations understand, measure and reduce their environmental and operational impact. The work is rooted in evidence and practicality — not frameworks for their own sake.
We quantify operational cost, supplier risk and Scope 1, 2 and 3 emissions using GHG Protocol and ISO 14064 standards. Data-driven baselines you can defend under audit.
We deliver audit-ready dashboards and reporting that align with NHS Net Zero, ESG demands, ISO compliance and customer questionnaires — without weeks of reconstruction every cycle.
We deliver clear, actionable strategies ranked by saving size, ease and risk. The action plan reads like an operational backlog with owners, timelines and expected outcomes — not a wishlist.
Field · SME laboratory operational environment
Lab spend is usually analysed at the line item — not at the operation. Consumables get ordered against habit. Waste streams sit unreviewed for years. Procurement is fragmented across teams. Energy-intensive equipment runs without visibility. The data needed for Scope 3 or customer reporting sits in spreadsheets — or doesn't exist at all.
Fragmented suppliers, parallel ordering, contract overlap and price drift quietly erode gross margin. Lab consumable inflation has outpaced pricing power for several years — and most of that pressure lands on the bottom line silently.
Unsegmented streams, oversized contractor pickups and disposable defaults inflate the third-largest line item in most SME labs. Single-use plastics — pipette tips, sterile packaging, plates — carry a hidden cost and a hidden footprint.
When a customer or auditor asks for emissions, energy or supplier data, most SME labs spend weeks reconstructing what should be a one-day answer.
Where avoidable cost, supplier risk and reporting gaps usually concentrate inside laboratories.
Over-ordering, expiry write-offs and parallel buying across teams.
Segregation, contractor pricing and disposal route inefficiencies.
Supplier fragmentation, contract leakage and consolidation opportunities.
Concentration, single-source exposure and price volatility mapping.
ULT freezers, autoclaves, fume hoods, fridge stacking and runtime patterns.
Disposal cost, single-use load and substitution feasibility.
Emissions baselining and supplier-sourced data readiness.
Customer questionnaires, framework alignment and audit response time.
Cold storage corridor · -20°C
Most ULT freezers run 24/7 at under 60% capacity — common in scale-up labs.
Cold storage runs 24/7. Most of it doesn't need to.
The same inefficiencies that erode your gross margin also generate your carbon footprint.
We don't separate the two engagements because, on the bench, they aren't separate problems. The ULT freezer running half-full costs you energy and inflates your Scope 2. The over-ordered reagent costs you write-off and inflates your Scope 3. One audit, two outcomes.
SOURCE · ATLAS OPERATIONS MODELEvery Baseline Audit produces five named outputs. No abstract recommendations.
A breakdown of where avoidable spend, disposal cost and material loss are concentrated, by line item.
Supplier concentration, contract overlap and substitution opportunities, ranked by saving size and ease of implementation.
A defensible starting position for reporting, even if your supplier data is incomplete.
Single-points-of-failure across supply, equipment, waste contracts and reporting, prioritised.
Specific actions with owner, timeline and expected saving range. Implementable, not aspirational.
Scope 3 typically dominates a healthcare or research organisation's footprint — and the same operational lines that drive it also drive your costs. We work at that intersection so you don't have to choose between sustainability performance and gross margin.
Most labs spend weeks reconstructing customer-questionnaire answers from scratch. Atlas-supported clients answer them in a day, from the same operational model that drives their cost recovery.
Lab consumable, reagent and waste costs have climbed faster than SME labs can pass through to customers. The result is silent gross margin erosion — visible in the year-end account, not in the day-to-day.
Supplier consolidation, shipping disruption and material substitution have made single-source procurement riskier than at any point in the last decade. A failed supplier is now an operational event, not an inconvenience.
Larger customers, framework operators and accreditation bodies are pushing emissions and operational disclosure down to mid-sized labs. The lab without an answer increasingly loses the tender.
If this isn't being managed actively, it is being absorbed silently — usually as eroded gross margin.
From pipette tips to sterile packaging, single-use plastics are essential for hygiene and research precision. Yet they carry a hidden environmental — and operational — cost. The same lines that drive your disposal bill drive your Scope 3 footprint.
We don't ask you to choose between operations and sustainability. Carbon, waste and material improvements come from the same work that strips out cost — because the same inefficiencies cause both.
If you need a Scope 3 baseline or customer-facing emissions data, we produce it as a built-in output, not a separate workstream.
Pipette tip waste · disposal point
Over 60% of lab disposal volume is single-use plastic — most unrecycled.
Single-use plastic load — typical SME lab
Typical SME lab — relative single-use composition, illustrative
Atlas structures audit data, maps consumables and waste, calculates emissions, compares suppliers, generates recommendations and tracks implementation. Every engagement is supported by it.
We don't sell Atlas as software. We use it to deliver faster, deeper, more defensible work.
See how Atlas worksWhat lab directors usually want to know — before they spend any time on a Discovery Call.
Bridging academic insight with real-world implementation. Our recommendations have to clear two tests: methodology defensible under audit, and operable inside an actual lab next quarter. We don't publish either-or work.
Biomedical, environmental and carbon modelling, brought together as a single delivery team. The audit doesn't need to be re-explained between specialists — because the specialists are working from the same operational model.
Data you can trust, results you can track. Every figure carries a methodology note. Every recommendation is costed. Every action has an owner and a saving range. Nothing is left as "consider" — only as "do, and by when".
20 minutes, no prep, no pitch. We listen, then tell you what we'd recommend.
Within 2 working days of the call. No retainers, no bundles, no surprises.
4–6 weeks, end to end. Five named outputs and a 12-month action plan.
Optional ongoing support. Atlas-tracked progress and customer reporting on demand.
We'll ask about your lab footprint, current cost pressures, reporting requirements and any specific concerns. If a Baseline Audit is the right next step, we'll scope it. If it isn't, we'll say so.